Ikeda, Yasuo

One-year cardiovascular event rates in outpatients with atherothrombosis

Steg, P. G., Bhatt, D. L., Wilson, P. W. F., D’Agostino, R., Ohman, E. M., Röther, J., Liau, C.-S., Hirsch, A. T., Mas, J.-L., Ikeda, Y., et al. (2007) · JAMA

Lipoproteins and Cardiovascular HealthAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,382

Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells

Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K., Hosokawa, K., Ikeda, Y., et al. (2006) · Nature Medicine

Hematopoietic Stem Cell TransplantationRedox biology and oxidative stress

Cited by 1,362

Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells

Ito, K., Hirao, A., Arai, F., Matsuoka, S., Takubo, K., Hamaguchi, I., Nomiyama, K., Hosokawa, K., Sakurada, K., Nakagata, N., et al. (2004) · Nature

Hematopoietic Stem Cell TransplantationDNA Repair Mechanisms

Cited by 1,175

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood

Viral-associated cancers and disordersAutoimmune and Inflammatory Disorders Research

Cited by 754

Fucoidan induces apoptosis of human HS-Sultan cells accompanied by activation of caspase-3 and down-regulation of ERK Pathways

Aisa, Y., Miyakawa, Y., Nakazato, T., Shibata, H., Saito, K., Ikeda, Y., & Kizaki, M. (2005) · American Journal of Hematology

Seaweed-derived Bioactive CompoundsCell death mechanisms and regulation

Cited by 307

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors: A Randomized Clinical Trial

Ikeda, Y., Shimada, K., Teramoto, T., Uchiyama, S., Yamazaki, T., Oikawa, S., Sugawara, M., Ando, K., Murata, M., Yokoyama, K., et al. (2014) · JAMA

Antiplatelet Therapy and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 301

Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit

Yanagihara, K., Kitagawa, Y., Tomonaga, M., Tsukasaki, K., Kohno, S., Seki, M., Sugimoto, H., Shimazu, T., Tasaki, O., Matsushima, A., et al. (2010) · Critical Care

Bacterial Identification and Susceptibility TestingSepsis Diagnosis and Treatment

Cited by 104

Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

Uchiyama, S., Goto, S., Matsumoto, M., Nagai, R., Origasa, H., Yamazaki, T., Shigematsu, H., Shimada, K., Yamada, N., Bhatt, D. L., et al. (2009) · Journal of the Neurological Sciences

Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery Diseases

Cited by 59

One-Year Cardiovascular Event Rates in Japanese Outpatients With Myocardial Infarction, Stroke, and Atrial Fibrillation: – Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE) –

Goto, S., Ikeda, Y., Shimada, K., Uchiyama, S., Origasa, H., Kobayashi, H., & The J-TRACE Investigators (2011) · Circulation Journal

Atrial Fibrillation Management and OutcomesAcute Myocardial Infarction Research

Cited by 35